Nicotinamide N-methyltransferase sustains a core epigenetic program that promotes metastatic colonization in breast cancer.
Saved in:
| Title: | Nicotinamide N-methyltransferase sustains a core epigenetic program that promotes metastatic colonization in breast cancer. |
|---|---|
| Authors: | Couto JP; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Vulin M; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Jehanno C; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland., Coissieux MM; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Hamelin B; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland., Schmidt A; Proteomics Core Facility, Biozentrum, University of Basel, Basel, Switzerland., Ivanek R; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland., Sethi A; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland., Bräutigam K; Computational and Translational Pathology Group, Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zürich, Switzerland.; Institute of Pathology, University of Bern, Bern, Switzerland., Frei AL; Computational and Translational Pathology Group, Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zürich, Switzerland., Hager C; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland., Manivannan M; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland., Gómez-Miragaya J; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland., Obradović MM; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Varga Z; Computational and Translational Pathology Group, Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zürich, Switzerland., Koelzer VH; Computational and Translational Pathology Group, Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zürich, Switzerland., Mertz KD; Institute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland., Bentires-Alj M; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. |
| Source: | The EMBO journal [EMBO J] 2023 Jul 03; Vol. 42 (13), pp. e112559. Date of Electronic Publication: 2023 Jun 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2075 |
|---|---|
| DOI: | 10.15252/embj.2022112559 |
